Michael Weiser, Director at IOVANCE BIOTHERAPEUTICS, INC. (IOVA), bought 17,813 shares at $6.80 ($121K) on 2022-05-31, disclosed to the SEC on 2022-06-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.79 | 2,187 | $15K | 12.3% |
| 2 | $6.80 | 7,813 | $53K | 43.9% |
| 3 | $6.80 | 7,813 | $53K | 43.9% |
| Total | $6.80 avg | 17,813 | $121K | 100% |
| Filing → |
| CHTP | BUY | 2008-10-06 | $3K | — | Filing → |
| CHTP | BUY | 2008-09-24 | $4K | — | Filing → |
| HNAB | BUY | 2008-05-15 | $8K | — | Filing → |